New China-Denmark Food & Drug Regulatory Cooperation Centre

The European Regulatory Town Hall Meeting convened against a compelling backdrop – including the official adoption of new medical device and in vitro diagnostic device regulations in Europe, Brexit, and uncertainty surrounding the future and future location of the European Medicines Agency – at our DIA EuroMeeting 2017. In this exclusive Global Forum podcast, Dr. Thomas Senderovitz, Director General of the Danish Medicines Agency and one of our European Regulatory Town Hall panelists, discusses the importance of multi-stakeholder collaboration in drug development and regulation, and introduces the new China-Denmark Food & Drug Regulatory Cooperation Centre. “It’s the largest operation of its kind that the Chinese FDA has ever signed, and we’re the first country in the world to go into this type of collaboration,” he explains. “Within this framework, we’re going to exchange best practices, telephone conferences, seminars, and staff exchanges for shorter or longer durations of time in areas such as licensing, inspection, medical devices, procedures, guidelines, etc.” To learn more, attend sessions in the Regulatory Track at our DIA 2017 Global Annual Meeting.